Last reviewed · How we verify

NCT06954649: Hypolypox

Evaluation of the Functionality of an Extract Rich in Phytosterols and Phytostanols on Parameters Related to the Lipid Profile of Individuals With Hypercholesterolemia, Mainly in the Levels of Total Cholesterol, LDL Cholesterol and Oxidized LDL

Completed NA Last updated 1 May 2025
What this trial tests

NA trial testing Plant based extract rich in phytosterols and phytostanols resveratrol and hydroxytyrosol. in Cholesterol Lowering in 45 participants. Completed in 27 March 2025.

Timeline
14 January 2025
Primary endpoint
24 February 2025
27 March 2025

Quick facts

Lead sponsorCentro de Edafología y Biología Aplicada del Segura
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment45
Start date14 January 2025
Primary completion24 February 2025
Estimated completion27 March 2025
Sites2 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Centro de Edafología y Biología Aplicada del Segura

Who can join

Eligibility, any sex, with Cholesterol Lowering or LDL Level. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this clinical trial is to evaluate the functionality of an extract rich in phytosterols and phytostanols on parameters related to the lipid profile of individuals with hypercholesterolemia, mainly on total cholesterol and LDL cholesterol levels

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centro de Edafología y Biología Aplicada del Segura trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06954649.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing